KIRLYNXA

Swiss trademark · 657659 · Word mark · Deleted

Register entry

Registration number
657659
Application number
51120/2014
Status
Deleted
Type
Word mark
Filed
Jan 29, 2014
Registered
Apr 22, 2014
Published
Apr 22, 2014
Deleted
Aug 22, 2024
Reason
Not renewed
Priority
15.08.2013 US
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate und Substanzen zur Behandlung von viralen, metabolischen, endokrinen, muskuloskelettalen, kardiovaskulären, kardiopulmonalen, urogenitalen, onkologischen, hepatologischen, ophthalmischen, respiratorischen, neurologischen, gastrointestinalen, hormonellen, dermatologischen, psychiatrischen und das Immunsystem sowie sexuelle Dysfunktion betreffenden Erkrankungen und Störungen; Impfstoffe.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 22, 2024

    Deleted, not renewed

    Status of protective title
    Active → Cancelled
    Cancellation date
    22.08.2024
    Cause for cancellation
    Cancellation due to non-renewal

    Published in Swissreg on 22.08.2024

  2. Jan 31, 2024

    Agent’s address changed

    Representative
    Baker & McKenzie Zurich, Holbeinstrasse 30, 8034 Zürich → Baker McKenzie Switzerland AG, Holbeinstrasse 30, 8034 Zürich

    Published in Swissreg on 31.01.2024

  3. Jan 30, 2019

    Transferred

    Owner
    AbbVie Inc., 1 North Waukegan Road, North Chicago, IL 60064, USA → AbbVie Ireland Unlimited Company, 2 Church Street, Hamilton HM 11, Bermuda

    Published in Swissreg on 30.01.2019

  4. Apr 22, 2014

    Registered

    Published in Swissreg on 22.04.2014

Parties

Holder

AbbVie Ireland Unlimited Company

2 Church Street, Hamilton HM 11, BM

Agent

Baker McKenzie Switzerland AG

Holbeinstrasse 30, 8034 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.